Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Børresen AL[au]:

Oncogenesis in ovarian cancer. Børresen AL et al. Acta Obstet Gynecol Scand Suppl. (1992)

Detection of DNA variation in cancer. Hovig E et al. Pharmacogenetics. (1992)

Breast cancer information on the web. Friend S et al. Nat Genet. (1995)

Search results

Items: 1 to 50 of 147

1.

Mismatch detection using heteroduplex analysis.

Børresen AL.

Curr Protoc Hum Genet. 2002 Aug;Chapter 7:Unit 7.3. doi: 10.1002/0471142905.hg0703s33.

PMID:
18428333
2.

Detection of mutations by single-strand conformation polymorphism (SSCP) analysis and SSCP-hybrid methods.

Warren W, Hovig E, Smith-Sørensen B, Børresen AL, Fujimura FK, Liu Q, Feng J, Sommer SS.

Curr Protoc Hum Genet. 2001 May;Chapter 7:Unit 7.4. doi: 10.1002/0471142905.hg0704s15.

PMID:
18428305
3.

Mutations in exons 5-8 of the p53 gene, independent of their type and location, are associated with increased apoptosis and mitosis in invasive breast carcinoma.

van Slooten HJ, van De Vijver MJ, Borresen AL, Eyfjörd JE, Valgardsdóttir R, Scherneck S, Nesland JM, Devilee P, Cornelisse CJ, van Dierendonck JH.

J Pathol. 1999 Dec;189(4):504-13.

PMID:
10629550
4.

GSTM1 and NAT2 polymorphisms in operable and non-operable lung cancer patients.

Hou SM, Ryberg D, Fält S, Deverill A, Tefre T, Børresen AL, Haugen A, Lambert B.

Carcinogenesis. 2000 Jan;21(1):49-54.

PMID:
10607733
5.

Angiogenesis does not predict clinical response to doxorubicin monotherapy in patients with locally advanced breast cancer.

Paulsen T, Aas T, Børresen AL, Varhaug JE, Lønning PE, Akslen LA.

Int J Cancer. 1997 Feb 20;74(1):138-40. No abstract available.

6.

Relationship between abnormal p53 protein and failure to express p21 protein in human breast carcinomas.

Bukholm IK, Nesland JM, Kåresen R, Jacobsen U, Børresen AL.

J Pathol. 1997 Feb;181(2):140-5.

PMID:
9120716
7.

A segregation analysis of testicular cancer based on Norwegian and Swedish families.

Heimdal K, Olsson H, Tretli S, Fosså SD, Børresen AL, Bishop DT.

Br J Cancer. 1997;75(7):1084-7.

8.

A common BRCA1 mutation in Norwegian breast and ovarian cancer families?

Andersen TI, Børresen AL, Møller P.

Am J Hum Genet. 1996 Aug;59(2):486-7. No abstract available.

9.

Specific P53 mutations are associated with de novo resistance to doxorubicin in breast cancer patients.

Aas T, Børresen AL, Geisler S, Smith-Sørensen B, Johnsen H, Varhaug JE, Akslen LA, Lønning PE.

Nat Med. 1996 Jul;2(7):811-4.

PMID:
8673929
10.

Involvement of the pRb/p16/cdk4/cyclin D1 pathway in the tumorigenesis of sporadic malignant melanomas.

Maelandsmo GM, Flørenes VA, Hovig E, Oyjord T, Engebraaten O, Holm R, Børresen AL, Fodstad O.

Br J Cancer. 1996 Apr;73(8):909-16.

11.

Risk of cancer in relatives of testicular cancer patients.

Heimdal K, Olsson H, Tretli S, Flodgren P, Børresen AL, Fossa SD.

Br J Cancer. 1996 Apr;73(7):970-3.

12.

Familial testicular cancer in Norway and southern Sweden.

Heimdal K, Olsson H, Tretli S, Flodgren P, Børresen AL, Fossa SD.

Br J Cancer. 1996 Apr;73(7):964-9.

13.

Alterations of p53 and expression of WAF1/p21 in human thyroid tumors.

Zedenius J, Larsson C, Wallin G, Bäckdahl M, Aspenblad U, Höög A, Børresen AL, Auer G.

Thyroid. 1996 Feb;6(1):1-9.

PMID:
8777377
14.

TP53 alterations in atypical ductal hyperplasia and ductal carcinoma in situ of the breast.

Chitemerere M, Andersen TI, Holm R, Karlsen F, Børresen AL, Nesland JM.

Breast Cancer Res Treat. 1996;41(2):103-9.

PMID:
8944328
15.

Somatic mutations in the hMSH2 gene in microsatellite unstable colorectal carcinomas.

Børresen AL, Lothe RA, Meling GI, Lystad S, Morrison P, Lipford J, Kane MF, Rognum TO, Kolodner RD.

Hum Mol Genet. 1995 Nov;4(11):2065-72.

PMID:
8589682
16.

Deletion of 1p loci and microsatellite instability in colorectal polyps.

Lothe RA, Andersen SN, Hofstad B, Meling GI, Peltomäki P, Heim S, Brøgger A, Vatn M, Rognum TO, Børresen AL.

Genes Chromosomes Cancer. 1995 Nov;14(3):182-8.

PMID:
8589034
17.

Breast cancer information on the web.

Friend S, Borresen AL, Brody L, Casey G, Devilee P, Gayther S, Goldgar D, Murphy P, Weber BL, Wiseman R.

Nat Genet. 1995 Nov;11(3):238-9. No abstract available.

PMID:
7581445
18.

Molecular genetic changes in human male germ cell tumors.

Lothe RA, Peltomäki P, Tommerup N, Fosså SD, Stenwig AE, Børresen AL, Nesland JM.

Lab Invest. 1995 Nov;73(5):606-14.

PMID:
7474934
19.

[Early diagnosis of colorectal tumors].

Lothe RA, Børresen AL.

Tidsskr Nor Laegeforen. 1995 Oct 30;115(26):3231-2. Norwegian. No abstract available.

PMID:
7482447
20.

TP53 mutations and abnormal p53 protein staining in breast carcinomas related to prognosis.

Thorlacius S, Thorgilsson B, Björnsson J, Tryggvadottir L, Börresen AL, Ogmundsdottir HM, Eyfjörd JE.

Eur J Cancer. 1995 Oct;31A(11):1856-61.

PMID:
8541113
21.

TP53 mutations and breast cancer prognosis: particularly poor survival rates for cases with mutations in the zinc-binding domains.

Børresen AL, Andersen TI, Eyfjörd JE, Cornelis RS, Thorlacius S, Borg A, Johansson U, Theillet C, Scherneck S, Hartman S, et al.

Genes Chromosomes Cancer. 1995 Sep;14(1):71-5.

PMID:
8527388
23.

Detection of the poor metabolizer-associated CYP2D6(D) gene deletion allele by long-PCR technology.

Steen VM, Andreassen OA, Daly AK, Tefre T, Børresen AL, Idle JR, Gulbrandsen AK.

Pharmacogenetics. 1995 Aug;5(4):215-23.

PMID:
8528268
24.

TP53 mutations in prostatic cancer. Analysis of pre- and post-treatment archival formalin-fixed tumour tissue.

Berner A, Geitvik G, Karlsen F, Fosså SD, Nesland JM, Børresen AL.

J Pathol. 1995 Jul;176(3):299-308.

PMID:
7674092
25.

Localization of an ataxia-telangiectasia gene to an approximately 500-kb interval on chromosome 11q23.1: linkage analysis of 176 families by an international consortium.

Lange E, Borresen AL, Chen X, Chessa L, Chiplunkar S, Concannon P, Dandekar S, Gerken S, Lange K, Liang T, et al.

Am J Hum Genet. 1995 Jul;57(1):112-9.

26.

TP53 gene mutations and protein accumulation in primary vaginal carcinomas.

Skomedal H, Kristensen G, Helland A, Nesland JM, Kooi S, Børresen AL, Holm R.

Br J Cancer. 1995 Jul;72(1):129-33.

27.

Association studies of estrogen receptor polymorphisms in a Norwegian testicular cancer population.

Heimdal K, Andersen TI, Skrede M, Fosså SD, Berg K, Børresen AL.

Cancer Epidemiol Biomarkers Prev. 1995 Mar;4(2):123-6.

28.

Alterations at chromosome 17 loci in peripheral nerve sheath tumors.

Lothe RA, Slettan A, Saeter G, Brøgger A, Børresen AL, Nesland JM.

J Neuropathol Exp Neurol. 1995 Jan;54(1):65-73.

PMID:
7815081
29.
30.

Oestrogen receptor (ESR) polymorphisms and breast cancer susceptibility.

Andersen TI, Heimdal KR, Skrede M, Tveit K, Berg K, Børresen AL.

Hum Genet. 1994 Dec;94(6):665-70.

PMID:
7989041
31.

Genetic haplotyping of ataxia-telangiectasia families localizes the major gene to an approximately 850 kb region on chromosome 11q23.1.

Gatti RA, Lange E, Rotman G, Chen X, Uhrhammer N, Liang T, Chiplunkar S, Yang L, Udar N, Dandekar S, Sheikhavandi S, Wang Z, Yang HM, Polikow J, Elashoff M, Teletar M, Sanal O, Chessa L, McConville C, Taylor M, Shiloh Y, Porras O, Borresen AL, Wegner RD, Curry C, Gerken S, Lange K, Concannon P.

Int J Radiat Biol. 1994 Dec;66(6 Suppl):S57-62.

PMID:
7836853
32.

[Molecular pathology. A new diagnostic dimension].

Nesland JM, Børresen AL, Andersson LC.

Tidsskr Nor Laegeforen. 1994 Oct 30;114(26):3047-8. Norwegian. No abstract available.

PMID:
7974419
33.

DQA1 and DQB1 genes in patients with squamous cell carcinoma of the cervix: relationship to human papillomavirus infection and prognosis.

Helland A, Børresen AL, Kristensen G, Rønningen KS.

Cancer Epidemiol Biomarkers Prev. 1994 Sep;3(6):479-86.

34.

Association studies of a polymorphism in the Wilms' tumor 1 locus in Norwegian patients with testicular cancer.

Heimdal KR, Lothe RA, Fosså SD, Børresen AL.

Int J Cancer. 1994 Aug 15;58(4):523-6.

PMID:
8056449
35.

Evidence for a gene on 17p13.3, distal to TP53, as a target for allele loss in breast tumors without p53 mutations.

Cornelis RS, van Vliet M, Vos CB, Cleton-Jansen AM, van de Vijver MJ, Peterse JL, Khan PM, Børresen AL, Cornelisse CJ, Devilee P.

Cancer Res. 1994 Aug 1;54(15):4200-6.

36.

p53 alterations in gastric carcinoma: a study of 56 primary tumors and 204 nodal metastases.

Seruca R, David L, Castedo S, Veiga I, Børresen AL, Sobrinho-Simões M.

Cancer Genet Cytogenet. 1994 Jul 1;75(1):45-50.

PMID:
8039163
37.

Genetic alterations of chromosome 17 in human breast carcinoma studied by fluorescence in situ hybridization and molecular DNA techniques.

Rosenberg C, Andersen TI, Nesland JM, Lier ME, Brøgger A, Børresen AL.

Cancer Genet Cytogenet. 1994 Jul 1;75(1):1-5.

PMID:
8039157
38.

Germline mutations of the p53 tumor suppressor gene in children with osteosarcoma.

McIntyre JF, Smith-Sorensen B, Friend SH, Kassell J, Borresen AL, Yan YX, Russo C, Sato J, Barbier N, Miser J, et al.

J Clin Oncol. 1994 May;12(5):925-30.

PMID:
8164043
39.

Genotyping of the CYP2D6 gene in Norwegian lung cancer patients and controls.

Tefre T, Daly AK, Armstrong M, Leathart JB, Idle JR, Brøgger A, Børresen AL.

Pharmacogenetics. 1994 Apr;4(2):47-57.

PMID:
8081413
40.

p53 mutations in lung tumors: relationship to putative susceptibility markers for cancer.

Ryberg D, Kure E, Lystad S, Skaug V, Stangeland L, Mercy I, Børresen AL, Haugen A.

Cancer Res. 1994 Mar 15;54(6):1551-5.

41.

TP53 allele loss, mutations and expression in malignant melanoma.

Flørenes VA, Oyjord T, Holm R, Skrede M, Børresen AL, Nesland JM, Fodstad O.

Br J Cancer. 1994 Feb;69(2):253-9.

42.

Genome scanning of breast cancers by two-dimensional DNA typing.

Verwest AM, de Leeuw WJ, Molijn AC, Andersen TI, Börresen AL, Mullaart E, Uitterlinden AG, Vijg J.

Br J Cancer. 1994 Jan;69(1):84-92.

43.

Intragenic reorganization of RB1 in a complex (4;13) rearrangement demonstrated by FISH.

Rosenberg C, Janson M, Nordeskjöld M, Børresen AL, Vianna-Morgante AM.

Cytogenet Cell Genet. 1994;65(4):268-71.

PMID:
8258302
44.

[The 1993 Nobel Prize in chemistry--polymerase chain reaction and directed mutagenesis].

Børresen AL.

Tidsskr Nor Laegeforen. 1993 Dec 10;113(30):3668-9. Norwegian. No abstract available.

PMID:
8278946
45.

Genetic alterations of the TP53 gene, p53 protein expression and HPV infection in primary cervical carcinomas.

Helland A, Holm R, Kristensen G, Kaern J, Karlsen F, Trope C, Nesland JM, Børresen AL.

J Pathol. 1993 Oct;171(2):105-14.

PMID:
8283348
46.

K-ras oncogene codon 12 point mutations in testicular cancer.

Ridanpää M, Lothe RA, Onfelt A, Fosså S, Børresen AL, Husgafvel-Pursiainen K.

Environ Health Perspect. 1993 Oct;101 Suppl 3:185-7.

47.

Prognostic significance of TP53 alterations in breast carcinoma.

Andersen TI, Holm R, Nesland JM, Heimdal KR, Ottestad L, Børresen AL.

Br J Cancer. 1993 Sep;68(3):540-8.

48.

Genome scanning of human breast carcinomas using micro- and minisatellite core probes.

Hovig E, Mullaart E, Børresen AL, Uitterlinden AG, Vijg J.

Genomics. 1993 Jul;17(1):66-75.

PMID:
8104870
49.

Frequent loss of 11p13 and 11p15 loci in male germ cell tumours.

Lothe RA, Hastie N, Heimdal K, Fosså SD, Stenwig AE, Børresen AL.

Genes Chromosomes Cancer. 1993 Jun;7(2):96-101.

PMID:
7687459
50.

Genetic alterations in a malignant schwannoma from a patient with neurofibromatosis (NF1).

Lothe RA, Saeter G, Danielsen HE, Stenwig AE, Høyheim B, O'Connell P, Børresen AL.

Pathol Res Pract. 1993 May;189(4):465-71; discussion 471-4.

PMID:
8351250

Supplemental Content

Loading ...
Support Center